Skip to main content

Main menu

  • Home
  • Content
    • Current issue
    • Past issues
    • Early releases
    • Collections
    • Sections
    • Blog
    • Infographics & illustrations
    • Podcasts
    • COVID-19 articles
    • Obituary notices
  • Authors & Reviewers
    • Overview for authors
    • Submission guidelines
    • Submit a manuscript
    • Forms
    • Editorial process
    • Editorial policies
    • Peer review process
    • Publication fees
    • Reprint requests
    • Open access
    • Patient engagement
  • Physicians & Subscribers
    • Benefits for Canadian physicians
    • CPD Credits for CMA Members
    • Subscribe to CMAJ Print
    • Subscription prices
    • Obituary notices
  • Alerts
    • Email alerts
    • RSS
  • JAMC
    • À propos
    • Numéro en cours
    • Archives
    • Sections
    • Abonnement
    • Alertes
    • Trousse média 2023
    • Avis de décès
  • CMAJ JOURNALS
    • CMAJ Open
    • CJS
    • JAMC
    • JPN

User menu

Search

  • Advanced search
CMAJ
  • CMAJ JOURNALS
    • CMAJ Open
    • CJS
    • JAMC
    • JPN
CMAJ

Advanced Search

  • Home
  • Content
    • Current issue
    • Past issues
    • Early releases
    • Collections
    • Sections
    • Blog
    • Infographics & illustrations
    • Podcasts
    • COVID-19 articles
    • Obituary notices
  • Authors & Reviewers
    • Overview for authors
    • Submission guidelines
    • Submit a manuscript
    • Forms
    • Editorial process
    • Editorial policies
    • Peer review process
    • Publication fees
    • Reprint requests
    • Open access
    • Patient engagement
  • Physicians & Subscribers
    • Benefits for Canadian physicians
    • CPD Credits for CMA Members
    • Subscribe to CMAJ Print
    • Subscription prices
    • Obituary notices
  • Alerts
    • Email alerts
    • RSS
  • JAMC
    • À propos
    • Numéro en cours
    • Archives
    • Sections
    • Abonnement
    • Alertes
    • Trousse média 2023
    • Avis de décès
  • Visit CMAJ on Facebook
  • Follow CMAJ on Twitter
  • Follow CMAJ on Instagram
  • Listen to CMAJ podcasts
Letters

The authors respond to: “Case did not consider all potential causes of chilblains”

Malika A. Ladha and Elaine C. Dupuis
CMAJ September 08, 2020 192 (36) E1047; DOI: https://doi.org/10.1503/cmaj.76386
Malika A. Ladha
Resident physician, Division of Dermatology, Department of Medicine, University of Calgary, Calgary, Alta.
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Elaine C. Dupuis
Dermatologist, Division of Dermatology, Department of Medicine, University of Calgary, Calgary, Alta.
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Responses
  • Metrics
  • PDF
Loading

We thank Dr. Dewar1 for her interest in our CMAJ article.2 We considered a broad workup for contributory and aggravating causes and conducted a complete assessment during the clinical encounter. However, this could not all be captured within the article’s word limit. For clarification, we provide further details.

During the early months of the coronavirus disease 2019 (COVID-19) pandemic, our patient was assessed in-person in the emergency department, enabling a thorough history and a complete physical examination. Our patient had no history of nicotine or psychostimulant consumption. In addition, her review of systems was negative, including for those of autoimmune disorders and malignant disease (i.e., no fever, night sweats, weight changes, oral or genital ulcerations, photosensitivity, arthritis, arthralgias, morning stiffness, myalgias, muscle weakness, sicca symptoms or other cutaneous eruptions). The patient also did not have a family history of known autoimmune conditions. Other than the acral lesions described in our article, her physical examination was unremarkable. In particular, she had a normal body habitus without clinical signs of anorexia nervosa, no other cutaneous findings such as oral ulcerations or photo-distributed lesions, and normal nail capillaroscopy. We did not pursue a musculoskeletal examination given the lack of symptoms.

We completed a thorough panel of investigations to rule out systemic causes of chilblains. We did not conduct imaging investigations given the absence of respiratory symptoms before, during and after clinical encounter, and because chest imaging is not recommended to diagnose COVID-19 in patients with mild features.3 In addition, imaging would not have altered the cutaneous management.

We agree that a skin biopsy is not always required for diagnosis of chilblains because the findings are not pathognomonic but rather supportive of a clinical diagnosis. Our patient presented near the beginning of the pandemic when little was known about severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)-related chilblains. There have been reports of classic chilblains histology associated with SARS-CoV-2 infection, as well as superficial and deep lichenoid lymphocytic changes with basal vacuolar changes;4,5 microthrombi have also been described.6,7 A biopsy was completed to assess for microthrombi and to rule out vaso-occlusive pathology.

Idiopathic chilblains remain a diagnosis of exclusion. Patients presenting with chilblains should be appropriately examined and investigated to rule out secondary systemic causes. Our patient’s thorough history, physical examination and subsequent workup did not support any underlying disorder. Chilblains related to SARS-CoV-2 was favoured because of negative secondary workup, absence of cool/damp exposure and positive results for serology testing. The understanding of SARS-CoV-2-related chilblains and its pathogenesis will continue to evolve in the coming months.

Footnotes

  • Competing interests: None declared.

References

  1. ↵
    1. Dewar C
    . Case did not consider all potential causes of chilblains [letter]. CMAJ 2020;192:E1046.
    OpenUrlFREE Full Text
  2. ↵
    1. Ladha MA,
    2. Dupuis EC
    . SARS-CoV-2-related chilblains. CMAJ 2020;192:E804.
    OpenUrlFREE Full Text
  3. ↵
    1. Dennie C,
    2. Hague C,
    3. Lim RS,
    4. et al
    . Canadian Society of Thoracic Radiology/Canadian Association of Radiologists consensus statement regarding chest imaging in suspected and confirmed COVID-19. Can Assoc Radiol J 2020 May 8 [Epub ahead of print]. doi: 10.1177/0846537120924606.
    OpenUrlCrossRef
  4. ↵
    1. Kolivras A,
    2. Dehavay F,
    3. Delplace D,
    4. et al
    . Coronavirus (COVID-19) infection-induced chilblains: a case report with histopathological findings. JAAD Case Rep 2020;6:489–92.
    OpenUrl
  5. ↵
    1. Cordoro KM,
    2. Reynolds SD,
    3. Wattier R,
    4. et al
    . Clustered cases of acral perniosis: clinical features, histopathology and relationship to COVID-19. Pediatr Dermatol 2020;37:419–23.
    OpenUrl
  6. ↵
    1. Andina D,
    2. Noguera-Morel L,
    3. Bascuas-Arribas M,
    4. et al
    . Chilblains in children in the setting of COVID-19 pandemic. Pediatr Dermatol 2020;37: 406–11.
    OpenUrl
  7. ↵
    1. de Masson A,
    2. Bouaziz JD,
    3. Sulimovic L,
    4. et al
    . Chilblains are a common cutaneous finding during the COVID-19 pandemic: a retrospective nationwide study from France. J Am Acad Dermatol 2020;83:667–70.
    OpenUrl
PreviousNext
Back to top

In this issue

Canadian Medical Association Journal: 192 (36)
CMAJ
Vol. 192, Issue 36
8 Sep 2020
  • Table of Contents
  • Index by author

Article tools

Respond to this article
Print
Download PDF
Article Alerts
To sign up for email alerts or to access your current email alerts, enter your email address below:
Email Article

Thank you for your interest in spreading the word on CMAJ.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
The authors respond to: “Case did not consider all potential causes of chilblains”
(Your Name) has sent you a message from CMAJ
(Your Name) thought you would like to see the CMAJ web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
The authors respond to: “Case did not consider all potential causes of chilblains”
Malika A. Ladha, Elaine C. Dupuis
CMAJ Sep 2020, 192 (36) E1047; DOI: 10.1503/cmaj.76386

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
‍ Request Permissions
Share
The authors respond to: “Case did not consider all potential causes of chilblains”
Malika A. Ladha, Elaine C. Dupuis
CMAJ Sep 2020, 192 (36) E1047; DOI: 10.1503/cmaj.76386
Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like

Jump to section

  • Article
    • Footnotes
    • References
  • Responses
  • Metrics
  • PDF

Related Articles

  • SARS-CoV-2-related chilblains
  • PubMed
  • Google Scholar

Cited By...

  • Case did not consider all potential causes of chilblains
  • Google Scholar

More in this TOC Section

  • The 5 Ps need an update: toward a comprehensive sexual history
  • Don’t ignore perimenopause
  • Hospital-at-home programs in Canada: challenges and pitfalls
Show more Letters

Similar Articles

 

View Latest Classified Ads

Content

  • Current issue
  • Past issues
  • Collections
  • Sections
  • Blog
  • Podcasts
  • Alerts
  • RSS
  • Early releases

Information for

  • Advertisers
  • Authors
  • Reviewers
  • CMA Members
  • CPD credits
  • Media
  • Reprint requests
  • Subscribers

About

  • General Information
  • Journal staff
  • Editorial Board
  • Advisory Panels
  • Governance Council
  • Journal Oversight
  • Careers
  • Contact
  • Copyright and Permissions
CMAJ Group

Copyright 2023, CMA Impact Inc. or its licensors. All rights reserved. ISSN 1488-2329 (e) 0820-3946 (p)

All editorial matter in CMAJ represents the opinions of the authors and not necessarily those of the Canadian Medical Association or its subsidiaries.

To receive any of these resources in an accessible format, please contact us at CMAJ Group, 500-1410 Blair Towers Place, Ottawa ON, K1J 9B9; p: 1-888-855-2555; e: [email protected]

CMA Civility, Accessibility, Privacy

 

Powered by HighWire